In men with type 1 diabetes, intravenous glucose-dependent insulinotropic polypeptide can reduce postprandial plasma glucose ...

Z-endoxifen has demonstrated efficacy in phase 1 and 2 trials, improving progression-free survival and tumor response in ...

Today, exposure to synthetic chemicals is greater than at any other point in modern history, far beyond what the body’s ...

Struggling with weight gain or high blood pressure? High cortisol levels could be the reason, suggests a gastroenterologist.

Study is Evaluating Monthly Subcutaneous, Weekly Oral, and Daily Oral Regimens Designed to Explore Maintenance Dosing Regimens Following Initial Weight Loss with VK2735 ...

Experienced Industry Leader with More than Two Decades of Global Commercialization and Marketing ExpertiseSAN DIEGO, Jan. 7, 2026 /PRNewswire/ -- Viking ...

Indiana could join a growing number of states scrutinizing ultra-processed foods in schools under legislation heard Wednesday ...

As the name suggests, The Natural Deodorant Co specialises solely in natural odour busters, so it’s safe to say the brand is ...

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

Barely one in 1,000 stocks around the world reach Dividend King status by raising payouts for at least 50 years -- and it's ...

The U.S. FDA’s September 2022 final guidance for clinical decision support (CDS) systems set a dismal record for pushback, ...

Ernexa Therapeutics Inc. has successfully completed a pre-IND meeting with the FDA, setting a pathway toward submitting an IND and initiating a first-in-human trial for the treatment of ovarian cancer ...